Adolescence is a stage of development that in humans is often associated with increased levels of risk-taking and reckless behaviors. Furthermore, brain development underlying motivation and decision making processes makes this age period particularly vulnerable with respect to impulse control and the development of addiction. Therefore, the objective of this competitive renewal is to develop an effective pharmacologic treatment regimen for cocaine and/or methamphetamine addiction using S-(+)-gamma-vinyl GABA (GVG) in adolescent animals, a notably vulnerable population. Currently, no effective pharmacologic treatments are available for these indications in any population regardless of age. Thus, in addition to identifying effective treatment regimens, studies in this application will establish whether these regimens need to be modified in adults as the consequence of an adolescent drug history. Using a strategy similar to the one currently funded for racemic GVG, these studies will be targeted in several new directions. First, using adolescent animals, studies will identify an effective treatment regimen using the new molecular entity, S-(+)-GVG, the pharmacologically active enantiomer of GVG. Next, studies will determine if this regimen is effective once these animals reach adulthood and whether it remains effective in adult animals with an adolescent drug history of cocaine or methamphetamine exposure. These studies will use micro-PET imaging with 11C-raclopride as an independent measure of cocaine or methamphetamine-induced reward (increases in brain dopamine) and 18-FDG to identify glucose metabolic changes in dopaminergic and non-dopaminergic brain regions. Preliminary results demonstrate that all the proposed experiments can be completed as detailed. Ultimately, these data will be targeted towards the development of S-(+)-GVG for the treatment of cocaine and/or methamphetamine addiction in adolescence. Finally, these studies will determine if drug exposure during adolescence alters the adult therapeutic response to S-(+)-GVG.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA015041-04
Application #
6966693
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Acri, Jane
Project Start
2002-04-01
Project End
2008-08-31
Budget Start
2005-09-30
Budget End
2006-08-31
Support Year
4
Fiscal Year
2005
Total Cost
$346,360
Indirect Cost
Name
Brookhaven National Laboratory
Department
Type
DUNS #
027579460
City
Upton
State
NY
Country
United States
Zip Code
11973
Mirrione, Martine M; Konomos, Dorothy K; Gravanis, Iordanis et al. (2010) Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice. Neurobiol Dis 39:85-97
Pothakos, Konstantinos; Robinson, John K; Gravanis, Iordanis et al. (2010) Decreased serotonin levels associated with behavioral disinhibition in tissue plasminogen activator deficient (tPA-/-) mice. Brain Res 1326:135-42
DeMarco, Amy; Dalal, Reema M; Pai, Jessica et al. (2009) Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference. Synapse 63:87-94
Schiffer, Wynne K; Liebling, Courtney N B; Reiszel, Corinne et al. (2009) Cue-induced dopamine release predicts cocaine preference: positron emission tomography studies in freely moving rodents. J Neurosci 29:6176-85
Patel, Vinal D; Lee, Dianne E; Alexoff, David L et al. (2008) Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals. Neuroimage 41:1051-66
Lee, Dianne E; Pai, Jennifer; Mullapudui, Uma et al. (2008) The effects of inhaled acetone on place conditioning in adolescent rats. Pharmacol Biochem Behav 89:101-5
DeMarco, Amy; Dalal, Reema M; Kahanda, Milan et al. (2008) Subchronic racemic gamma vinyl-GABA produces weight loss in Sprague Dawley and Zucker fatty rats. Synapse 62:870-2
Marsteller, Douglas A; Barbarich-Marsteller, Nicole C; Patel, Vinal D et al. (2007) Brain metabolic changes following 4-week citalopram infusion: increased 18FDG uptake and gamma-amino butyric acid levels. Synapse 61:877-81
Mirrione, Martine M; Schiffer, Wynne K; Fowler, Joanna S et al. (2007) A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. Neuroimage 38:34-42
Schiffer, Wynne K; Liebling, Courtney N B; Patel, Vinal et al. (2007) Targeting the treatment of drug abuse with molecular imaging. Nucl Med Biol 34:833-47

Showing the most recent 10 out of 20 publications